Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein-calorie malnutrution

Journal of Pharmaceutical Sciences

Volumn 93, Issue 9, 2004, Pages 2388-2398

  Bae, Soo K ^a   Lee, Dae Y ^a   Lee, Ae K ^a   Kwon, Jong W ^b   Lee, Inchul ^c   Chung, Suk J ^a   Kim, Sang G ^a   Shim, Chang K ^a   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

^b Dong A Pharmaceutical Company   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

CYP2C11; Cysteine; Pharmacokinetics; Protein calorie malnutrition; Rats; Torasemide

Indexed keywords

CYSTEINE; CYTOCHROME P450 2C11; CYTOCHROME P450 2C9; TORASEMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; IN VITRO STUDY; MALE; MEAN RESIDENCE TIME; NONHUMAN; PROTEIN CALORIE MALNUTRITION; RAT; SEQUENCE HOMOLOGY;

EID: 4344583464     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20151     Document Type: Article

References (39)

1. Denke M, Wilson JD. 1998. Protein and energy malnutrition. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, editors. Principles of internal medicine, 14th ed. New York: McGraw-Hill, pp 452-454.
2. Buchanan N. 1978. Drug kinetics in protein energy malnutrition. S Afr Med J 53:327-330.
3. Krishnaswamy K. 1978. Drug metabolism and pharmacokinetics in malnutrition. Clin Pharmacokinet 3:216-240.
4. Cho MK, Kim YG, Lee MG, Kim SG. 1999. Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: Complete or partial restoration by cysteine or methionine supplementation. Arch Biochem Biophys 372:150-158.
5. Kim YG, Cho MK, Kwon JW, Kim SG, Kim SH, Lee MG. 2001. Effects of cysteine on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats with protein-calorie malnutrition. Life Sci 68:2329-2345.
6. Lee SH, Lee MG. 1997. Effect of phenobarbital, 3-methylcholanthrene, and chloramphenicol pretreatment on the pharmacokinetics and pharmacodynamics of azosemide in rats. Biopharm Drug Dispos 18:371-386.
7. Ahn CY, Kim EJ, Kwon JW, Chung SJ, Kim SG, Shim C-K, Lee MG. 2003. Effects of cysteine on the pharmacokinetics of intravenous clarithromycin in rats with protein-calorie malnutrition. Life Sci 73:1783-1794.
8. Rodvold KA. 1999. Clinical pharmacokinetics of clarithromycin. Clin Pharmacokinet 37:385-398.
9. Lee AK, Ahn CY, Kim EJ, Kwon JW, Kim SG, Chung SJ, Shim C-K, Lee MG. 2003. Effects of cysteine on the pharmacokinetics of itraconazole in rats with protein-calorie malnutrition. Biopharm Drug Dispos 24:63-70.
10. Penzak SR, Gubbins PO, Gurley BJ, Wang PL, Saccente M. 1999. Grapefruit juice decreases the systemic availability of itaconazole capsules in healthy volunteers. Ther Drug Monitor 21:304-309.
11. Janssen Pharmaceutica and Research Foundation, Janssen One-to-One Customer Action Center, Janssen Pharmaceutica Products, LR, April, 2001, p 1.
12. Kim YG, Cho MK, Kwon JW, Kim D-H, Kim SG, Lee MG. 2003. Effects of cysteine on the pharmacokinetics of intravenous 2-(allylthio)pyrazine, a new chemprotective agent, in rats with protein-calorie malnutrition. Int J Pharm 255:1-11.
13. Kim YG, Cho MK, Kwon JW, Kim SG, Lee MG. 2000. Effects of cysteine on the pharmacokinetics of intravenous adriamycin in rats with protein-calorie malnutrition. Res Commun Mol Pathol Pharmacol 107:361-376.
14. Komori M, Oda Y. 1994. A major glucocorticoid-inducible P450 in rat liver is not P450 3A1. J Biochem 116:114-120.
15. Kim YG, Cho MK, Kwon JW, Kim SG, Chung SJ, Shim C-K, Lee MG. 2002. Effects of cysteine on the pharmacokinetics of intravenous chlorzoxazone in rats with protein-calorie malnutrition. Biopharm Drug Dispos 23:121-129.
16. Rockich K, Blouin R. 1999. Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats. Drug Metab Dispos 27:1074-1077.
17. Moon YJ, Lee AK, Chung HJ, Kim EJ, Kim SH, Lee DC, Lee I, Kim SG, Lee MG. 2003. Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats. Drug Metab Dispos 31:776-784.
18. Kim YG, Cho MK, Kwon JW, Kim SG, Chung SJ, Shim C-K, Lee MG. 2001. Effects of cysteine on the pharmacokinetics of intravenous phenytoin in rats with protein-calorie malnutrition. Int J Pharm 229:45-55.
19. Guengerich FP. 1990. Enzymatic oxidation of xenobiotic chemicals. Crit Rev Biochem Mol Biol 25:97-153.
20. Kawamura A, Yoshida Y, Kimura N, Oda H, Kakimuma A. 1999. Phosphorylation/dephasphorylation steps are crucial for the induction of CYP2B1 and CYP2B2 gene expression by phenobarbital. Biochem Biophys Res Commun 264:530-536.
21. Knauf H, Mutschler E. 1998. Clinical pharmacokinetics and pharmacodynamics of torasemide. Clin pharmacokin 34:1-24.
22. Wittner M, Stefano AD, Wangemann P, Greger R. 1991. How do loop diuretics act? Drugs 41:1-13.
23. Miners JO, Rees DLP, Valente L, Veronese ME, Birkett DJ. 1995. Human hepatic cytochrome P450 2C9 catlayzes the rate-limiting pathway of torasemide metabolism. J Pharmacol Exp Ther 272:1076-1081.
24. Lewis DFV. 1996. P450 substrate specificity and metabolism. In: Cytochromes P450 structure, function and mechanism. Bristol, PA: Talyor & Francis, p 123.
25. Kim EJ, Lee MG. 2003. Pharmacokinetics and pharmacodynamics of intravenous torasemide in mutant nagase analbuminemic rats. Biopharm Drug Dispos 24:27-35.
26. Lowry OH, Rosebrough NG, Farr AL, Randall RJ. 1951. Protein measurement with Folin phenol reagent. J Biol Chem 193:265-275.
27. Lineweaver H, Burk D. 1934. The determination of enzyme dissociation constants. J Am Chem Soc 56:658-666.
28. Ogiso T, Iwaki M, Tanaka H, Kobayashi E, Tanino T, Sawada A, Uno S. 1999. Pharmacokinetic drug interactions between ampiroxicam and sulfaphenazole in rats. Biol Pharm Bull 22:191-196.
29. Kim YC, Lee MG, Kim SH. 2003. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous torasemide. J Pharm Pharmacol 55:1515-1521.
30. Chiou WL. 1978. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J Pharmacokin Biopharm 6:539-546.
31. Gibaldi M, Perrier D. 1982. Pharmacokinetics, 2nd ed. New York: Marcel Dekker.
32. Chiou WL. 1980. New calculation method of mean total body clearance of drugs and its application to dosage regimens. J Pharm Sci 69:90-91.
33. Chiou WL. 1979. New calculation method of mean apparent drug volume of distribution and application to rational dosage regimen. J Pharm Sci 68:1067-1069.
34. Eatman FB, Colburn WA, Boxenbaum HG, Posmanter HN, Weinfeld RE, Ronfeld R, Weissman L, Moore JD, Gibaldi M, Kaplan SA. 1977. Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. J Pharmacokinet Biopharm 5:481-494.
35. Kim SH, Choi YM, Lee MG. 1993. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J Pharmacokinet Biopharm 21:1-17.
36. Davies B, Morris T. 1993. Physiological parameters in laboratory animals and humans. Pharm Res 10:1093-1095.
37. Mitruka BM, Rawnsley HM. 1981. Clinical biochemical and hematological reference values in normal experimental animals and normal humans, 2nd ed. New York: Masson Publishing USA Inc., p 67.
38. Lee MG, Chiou WL. 1983. Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolism. J Pharmacokinet Biopharm 11:623-640.
39. Wilkinson GR, Shand DG. 1975. A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377-390.